Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - MABVAX THERAPEUTICS HOLDINGS, INC. | d587322d8k.htm |
Exhibit 16.1
August 23, 2013
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01(a) of Form 8-K dated August 23, 2013, of Telik, Inc. and are in agreement with the statements contained in the first, second, third and fourth paragraphs on page 2 therein.
/s/ Ernst & Young LLP